Zingiber officinale driven bioproduction of ZnO nanoparticles and their anti-inflammatory, anti-diabetic, anti-Alzheimer, anti-oxidant, and anti-microbial applications

…, M Rizwan, N Zaman, M Iqbal, A Iqbal… - Inorganic Chemistry …, 2022 - Elsevier
In the production of nanoparticles that utilizing biological products, bioinspired or green
nanotechnology gained significance every single day owing to its ecofriendly and cost-effective …

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy

…, SS Neelapu, A Khurana, Y Lin, M Iqbal… - Blood …, 2022 - ashpublications.org
Polatuzumab vedotin (PV) is an antibody–drug conjugate targeting CD79b that is approved
for patients with relapsed/refractory large B-cell lymphoma (LBCL). Patients who relapse …

Cytokine release syndrome: current perspectives

H Murthy, M Iqbal, JC Chavez… - ImmunoTargets and …, 2019 - Taylor & Francis
Chimeric antigen receptor T cell (CART) therapy represents a novel and a paradigm-shifting
approach to treating cancer. Recent clinical successes have widened the applicability of …

[HTML][HTML] Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

…, S Jaglowski, AS Kittai, N Denlinger, M Iqbal… - …, 2023 - ncbi.nlm.nih.gov
Allogeneic hematopoietic cell transplantation (alloHCT) can potentially salvage large B-cell
lymphoma (LBCL) patients experiencing treatment failure after chimeric antigen receptor T-…

[HTML][HTML] Green synthesis and characterization of copper and nickel hybrid nanomaterials: Investigation of their biological and photocatalytic potential for the removal of …

…, S Faisal, M Rizwan, N Zaman, M Iqbal, A Iqbal… - Journal of Saudi …, 2022 - Elsevier
Nanotechnology deals with the materials at nanoscale to synthesize nanoparticles. The
current study introduced a new green approach for the synthesis of Copper and Nickel hybrid …

[HTML][HTML] Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

…, VR Alegria, A Paulus, S Aulakh, M Iqbal… - Blood cancer …, 2019 - nature.com
With improving survivorship in chronic lymphocytic leukemia (CLL), the risk of second primary
malignancies (SPMs) has not been systematically addressed. Differences in risk for SPMs …

[HTML][HTML] Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?

…, JCV Bisneto, PB Johnston, SM Ansell, M Iqbal… - Radiotherapy and …, 2022 - Elsevier
Purpose Analyze the pattern of disease failure after anti-CD19-directed chimeric antigen
receptor T-cell therapy (CART) for non-Hodgkin lymphoma, assess the local control rate of …

[HTML][HTML] Correlation between Internet addiction, depression, anxiety and stress among undergraduate medical students in Azad Kashmir

A Javaeed, M Bint Zafar, M Iqbal… - Pakistan journal of …, 2019 - ncbi.nlm.nih.gov
Objective: To find out the correlation between internet addiction and depression, anxiety,
and stress among undergraduate medical students in Azad Kashmir. Methods: A cross-…

Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials

F Yassine, M Iqbal, H Murthy… - Current Research in …, 2020 - Elsevier
Advances in the field of immuno-oncology brought chimeric antigen receptor T (CAR T) cell
therapy from the bench to the bedside for treatment of relapsed and/or refractory B-cell …

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

…, R Tamari, A Bashey, A Keyzner, M Iqbal… - Leukemia, 2022 - nature.com
We report the results from a multicenter retrospective study of 69 adult patients who
underwent haploidentical blood or marrow transplantation (haplo-BMT) with post-transplantation …